214 related articles for article (PubMed ID: 24417951)
1. Adiponectin as a routine clinical biomarker.
Kishida K; Funahashi T; Shimomura I
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):119-30. PubMed ID: 24417951
[TBL] [Abstract][Full Text] [Related]
2. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin.
Hossain MM; Mukheem A; Kamarul T
Life Sci; 2015 Aug; 135():55-67. PubMed ID: 25818192
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and the cardiometabolic syndrome: an epidemiological perspective.
Funahashi T; Matsuzawa Y
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):93-106. PubMed ID: 24417949
[TBL] [Abstract][Full Text] [Related]
4. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
[TBL] [Abstract][Full Text] [Related]
5. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
[TBL] [Abstract][Full Text] [Related]
6. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes.
Monickaraj F; Gokulakrishnan K; Prabu P; Sathishkumar C; Anjana RM; Rajkumar JS; Mohan V; Balasubramanyam M
Clin Biochem; 2012 Nov; 45(16-17):1432-8. PubMed ID: 22827962
[TBL] [Abstract][Full Text] [Related]
7. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
8. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
10. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
[TBL] [Abstract][Full Text] [Related]
11. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?
Brooks NL; Moore KS; Clark RD; Perfetti MT; Trent CM; Combs TP
Diabetes Obes Metab; 2007 May; 9(3):246-58. PubMed ID: 17391150
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin.
Kishida K; Funahashi T; Shimomura I
Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):118-31. PubMed ID: 22236026
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin: a key adipocytokine in metabolic syndrome.
Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
[TBL] [Abstract][Full Text] [Related]
14. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
Siddiqui MB; Patel S; Arshad T; Lee E; Albhaisi S; Driscoll C; Wolver S; Reichman T; Bhati C; Siddiqui MS
Transplantation; 2019 Nov; 103(11):2323-2328. PubMed ID: 30946215
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
18. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
Tretjakovs P; Jurka A; Bormane I; Mackevics V; Mikelsone I; Balode L; Reihmane D; Stukena I; Bahs G; Aivars JI; Pirags V
Eur J Intern Med; 2009 Nov; 20(7):712-7. PubMed ID: 19818293
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
20. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
